Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
This informational resource ensures researchers know exactly what strength of peptide they are referencing or purchasing, regardless of the vendors label
Consistent medical supervision is not just a preliminary step but an ongoing requirement for success
Vision disturbances
Description DSIP is a synthetic nonapeptide supplied as a lyophilized research material for in vitro and analytical laboratory applications
KEY TAKEAWAYS The United States accounts for 41% of global Health Management Solutions ventures, making it the largest market for Health Management Solutions innovation globally
